Nicole White
Corporate Officer/Principal en ASSEMBLY BIOSCIENCES, INC. .
Fortuna: 174 014 $ al 30/04/2024
Perfil
Nicole S.
White is currently the Chief Manufacturing Officer at Assembly Biosciences, Inc. She started this position in 2022.
Prior to her current role, she worked at Gossamer Bio, Inc. as the Senior Director & Head-Process Chemistry from 2019 to 2020.
Before that, she was the Director-CMC at Abide Therapeutics, Inc. from 2017 to 2018.
Nicole's earliest position was as a Principal at Gilead Sciences, Inc. from 2009 to 2015.
She holds a doctorate degree from the University of California, Irvine and an undergraduate degree from the University of California San Diego.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
30/04/2024 | 13 025 ( 0.24% ) | 174 014 $ | 30/04/2024 |
Cargos activos de Nicole White
Empresas | Cargo | Inicio |
---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | 17/11/2020 |
Antiguos cargos conocidos de Nicole White.
Empresas | Cargo | Fin |
---|---|---|
GOSSAMER BIO, INC. | Corporate Officer/Principal | 01/11/2020 |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/04/2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2015 |
Formación de Nicole White.
University of California, Irvine | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
GOSSAMER BIO, INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Nicole White